Current Medical Research & Opinion
(CURR MED RES OPIN ) 《当前医学研究与观点 》

"Current Medical Research & Opinion's mission is to validate high quality articles through rigorous peer review, and to be a leader in transparency by facilitating a collaborative and honest approach to publication.Current Medical Research & Opinion aims to bridge the gap between industry breakthrough and point of care by providing physicians and other healthcare professionals with therapeutically innovative and clinically relevant information that has the potential to inform and impact medical practice. We welcome the following contributions:

 

    * Full-length articles reporting the original results of Phase II–IV studies and post-marketing investigations. Equiva-lence, safety and efficacy/effectiveness studies are encouraged.

    * Information on pharmaceutical preparations and medical devices, including therapeutic diagnostic (theranostic) products and over-the-counter medicines, as well as ethical pharmaceutical products and prescription-only medicines.

    * Review articles on new and existing drugs; drug classes and therapeutic areas; and disease states.

    * Brief Reports, Commentaries and Research Letters that meet the above criteria, and Letters to the Editor briefly commenting on work previously published in the journal. (A full description of types of article is included on page VIII of the CMRO Notes for Contributors PDF document.)

Supplements are also published and encouraged. These include both stand-alone and in-journal supplements based on symposia proceedings (sponsored workshops, meetings, webinars, webcasts, etc.), or collected articles on specific drugs or disease states. Enquiries from potential guest editors, meeting organizers and sponsors are welcomed. Supplements undergo the same rigorous peer review used for regular CMRO articles, and must adhere to CMRO's transparency policy and acknowledgments requirements."